Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D063 | ISIN: US2546041011 | Ticker-Symbol:
NASDAQ
27.06.25 | 20:43
54,95 US-Dollar
+1,44 % +0,78
1-Jahres-Chart
DISC MEDICINE INC Chart 1 Jahr
5-Tage-Chart
DISC MEDICINE INC 5-Tage-Chart

Aktuelle News zur DISC MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.06.Disc Medicine stock rating reiterated at Outperform by BMO Capital1
13.06.Disc Medicine, Inc. - 8-K, Current Report2
12.06.Disc Medicine Inc: Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress1
14.05.Disc Medicine Inc: Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress2
07.05.Disc Medicine, Inc. - 10-Q, Quarterly Report1
07.05.Disc Medicine, Inc. Q1 Loss Beats Estimates-
07.05.Disc Medicine GAAP EPS of -$1.02 beats by $0.061
07.05.Disc Medicine Inc: Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update353Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with...
► Artikel lesen
DISC MEDICINE Aktie jetzt für 0€ handeln
07.05.Disc Medicine, Inc. - 8-K, Current Report1
05.03.Cantor Fitzgerald maintains Overweight rating on Disc Medicine stock3
03.03.Scotiabank raises Disc Medicine stock target to $753
28.02.Disc Medicine GAAP EPS of -$3.96 beats by $1.011
27.02.Disc Medicine Inc: Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update337Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval pathway; on track to initiate APOLLO post-marketing confirmatory trial by mid-2025Positive...
► Artikel lesen
27.02.Disc Medicine, Inc. - 10-K, Annual Report-
27.02.Disc Medicine, Inc. - 8-K, Current Report-
27.02.TD Cowen starts Disc Medicine stock with Buy rating1
23.01.Disc Medicine announces pricing of $225.5M upsized public offering1
23.01.Disc Medicine Inc: Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants1
22.01.Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session6
21.01.Disc Medicine launches $200M offering3
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1